Treatment of severe leptospirosis with therapeutic plasma exchange in a pediatric patient

Faruk Ekinci1, R Dinçer Yıldızdaş1, Özden Özgür Horoz1

  • 1Department of Pediatrics, Division of Pediatric Intensive Care Unit, Çukurova University Faculty of Medicine, Adana, Turkey.

Insights

Severe leptospirosis in a child was successfully treated with therapeutic plasma exchange (TPE). This case highlights TPE as a potentially life-saving intervention for critical pediatric leptospirosis cases.

Area of Science:

  • Pediatric Intensive Care Medicine
  • Infectious Diseases
  • Nephrology

Background:

  • Leptospirosis, a zoonotic disease caused by Leptospira, presents a wide clinical spectrum, ranging from mild to fatal multi-organ involvement.
  • While prevalent in tropical regions, cases are reported globally, necessitating awareness and effective treatment strategies.

Observation:

  • An 8-year-old girl presented with severe leptospirosis, rapidly progressing to anuria, hypotension, and unconsciousness.
  • Clinical signs included fever, jaundice, petechiae, hepatomegaly, and severe hypotension.
  • Laboratory findings revealed elevated liver enzymes, bilirubin, creatinine, creatine kinase, and thrombocytopenia.

Findings:

  • The patient received mechanical ventilation, antibiotics, inotropic agents, penicillin G, continuous renal replacement therapy, and five daily sessions of therapeutic plasma exchange (TPE).
  • Leptospirosis diagnosis was confirmed by IgM testing and microscopic agglutination test.
  • The patient demonstrated complete recovery and was discharged from the pediatric intensive care unit.

Implications:

  • Therapeutic plasma exchange (TPE) may offer beneficial effects on clinical and laboratory findings in severe leptospirosis.
  • This case suggests TPE could improve survival rates in critically ill pediatric patients with leptospirosis.
  • Further research is warranted to establish the definitive role and efficacy of TPE in managing severe leptospirosis.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
203
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
262
Social Exchange Theory02:06

Social Exchange Theory

We have discussed why we form relationships, what attracts us to others, and different types of love. But what determines whether we are satisfied with and stay in a relationship? One theory that provides an explanation is social exchange theory. According to social exchange theory, we act as naïve economists in keeping a tally of the ratio of costs and benefits of forming and maintaining a relationship with others (Rusbult & Van Lange, 2003).
39.5K
Social Exchange Theory01:26

Social Exchange Theory

As formulated by John Thibaut and Harold Kelley, Social Exchange Theory explains human relationships as economic-like exchanges that maximize rewards and minimize costs. This theory suggests that individuals engage in relationships to gain benefits and reduce burdens, similar to economic transactions. It has been widely applied to various types of relationships, including romantic, professional, and social interactions.Rewards and Costs in RelationshipsRelationship rewards include emotional...
454